MOU with Novartis

MOU with Novartis

Busan Paik Hospital Clinical Trial Center (Busan Paik CTC) and Novartis

have agreed to conclude a Memorandum of Understanding

on General Collaboration (MOU).

Under this MOU, Busan Paik CTC and Novartis will share up-to-date knowledge

on pharmaceutical market and clinical trial field.

Busan Paik Hospital Clinical Trial Center has acumen to dedicating contributions

to the community and to international society.

Busan Paik CTC and Novartis are hoping this agreement will be the first step

to open up and to lead Asian clinical trial field.

On the other hand, in order to facilitate collaborative activities under this MOU,

Novartis plans to set up an office in newly expanded Busan Paik Hospital

Clinical Trial Center and this fact will bring both Busan Paik CTC and Novartis

a great chance to share inner thoughts and actual know- how on clinical trials.

The signing ceremony for the MOU will take place on October.